A detailed history of Allied Investment Advisors, LLC transactions in Geron Corp stock. As of the latest transaction made, Allied Investment Advisors, LLC holds 20,959 shares of GERN stock, worth $86,141. This represents 0.02% of its overall portfolio holdings.

Number of Shares
20,959
Previous 20,959 -0.0%
Holding current value
$86,141
Previous $88,000 7.95%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$1.19 - $1.65 $4,569 - $6,336
-3,840 Reduced 15.48%
20,959 $32,000
Q1 2022

Apr 11, 2022

BUY
$0.99 - $1.6 $24,551 - $39,678
24,799 New
24,799 $34,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.55B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Allied Investment Advisors, LLC Portfolio

Follow Allied Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allied Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allied Investment Advisors, LLC with notifications on news.